{"id":7979,"date":"2025-05-28T12:59:41","date_gmt":"2025-05-28T07:29:41","guid":{"rendered":"https:\/\/www.torusdigital.com\/toruscope\/?p=7979"},"modified":"2025-05-28T12:59:41","modified_gmt":"2025-05-28T07:29:41","slug":"stocks-to-buy-today-may-28-2025","status":"publish","type":"post","link":"https:\/\/www.torusdigital.com\/toruscope\/news\/stocks-to-buy-today-may-28-2025\/","title":{"rendered":"Stocks to Buy Today: May 28, 2025"},"content":{"rendered":"

[vc_section el_id=”blog-inner-layout”][vc_row overlay_dotted=””][vc_column el_class=”blog_primary”][vc_row_inner][vc_column_inner][vc_column_text css=””]In the opening trade session at around 9:21 am on May 28, 2025, the <\/span>Nifty 50<\/span><\/a> was up by 32 points, trading around 24,857.8 points, while the <\/span>Sensex<\/span><\/a> was marginally up by 45 points, trading at 81,596.7 points. However, volatility is expected throughout the day due to developments in international markets, companies declaring their fourth-quarter results, and ongoing trade talks. The weak dollar and gold prices from the US market will also influence today’s market direction. Amid all this, one stock worth tracking is <\/span>Syngene International Ltd<\/span><\/a>.<\/span><\/p>\n

<\/span>Stocks to Buy Today\u00a0<\/b><\/span><\/h2>\n

Here is the curated stock you may track in today\u2019s trading session:<\/span><\/p>\n

<\/span>Syngene International Ltd. (NSE: SYNGENE)<\/b><\/span><\/h3>\n

Syngene International<\/span> operates in the integrated research, development, and manufacturing sector. The company offers contract research services to biotechnology and<\/span> pharmaceutical<\/span><\/a> companies. Regarding their recently declared fourth-quarter results for the financial year 2024-25, the company has posted a net profit of \u20b9183.3 crores. The net sales for the same duration were \u20b91,018 crores, marking an 11% increase compared to the same quarter of the preceding financial year. With pipelines established for both large and small molecules and multiple pilot programs underway, the company expects to perform even better in the financial year 2025-26.<\/span><\/p>\n

Besides its financials, the company acquired a US biologics manufacturing site for $36.5 million a few months ago. The acquisition will help the company strengthen its position in both the animal and human health segments.<\/span><\/p>\n

In the span of a month, Syngene International has delivered a return of 3.9%. Key details of Syngene International Ltd. stocks:<\/span><\/p>\n\n\n\n\n\n\n\n
Closing Price (as of May 27, 2025)<\/span><\/td>\n\u20b9654.15<\/span><\/td>\n<\/tr>\n
Trading Volume<\/span><\/td>\n2,24,959<\/span><\/td>\n<\/tr>\n
Company Type<\/span><\/td>\nSmallcap<\/span><\/a>\u00a0<\/span><\/td>\n<\/tr>\n
Market Cap<\/span><\/td>\n\u20b926,231 crores\u00a0<\/span><\/td>\n<\/tr>\n
Beta<\/span><\/td>\n0.63<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

<\/span>Conclusion<\/b>\u00a0<\/span><\/span><\/h2>\n

Regardless of the stock you trade, adopt a precautionary approach for long-term success. Consider your financial goals, risk tolerance, and market conditions before trading. Implement a risk management strategy involving diversification, stop-loss orders, and position sizing to mitigate potential losses. This approach not only protects your capital but also improves your ability to capitalise on profitable market opportunities.<\/span><\/p>\n

Just starting out with investing? Begin your <\/span>stock market<\/span><\/a> journey by <\/span>opening a Demat Account<\/span><\/a> with Torus Digital today.<\/span><\/p>\n

 [\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner el_id=”share_rating”][vc_column_inner width=”1\/2″][vc_column_text css=””]<\/p>\n

Rate this article<\/h6>\n